As of 2026-04-04, the Intrinsic Value of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM.NS) is 618.98 INR. This JBCHEPHARM.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1,961.10 INR, the upside of J B Chemicals and Pharmaceuticals Ltd is -68.40%.
The range of the Intrinsic Value is 517.71 - 779.36 INR
Based on its market price of 1,961.10 INR and our intrinsic valuation, J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM.NS) is overvalued by 68.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 517.71 - 779.36 | 618.98 | -68.4% |
| DCF (Growth 10y) | 775.56 - 1,143.06 | 918.85 | -53.1% |
| DCF (EBITDA 5y) | 1,407.17 - 2,228.83 | 1,709.19 | -12.8% |
| DCF (EBITDA 10y) | 1,598.02 - 2,597.54 | 1,968.13 | 0.4% |
| Fair Value | 1,044.74 - 1,044.74 | 1,044.74 | -46.73% |
| P/E | 891.26 - 1,211.23 | 984.28 | -49.8% |
| EV/EBITDA | 1,044.77 - 1,772.71 | 1,329.94 | -32.2% |
| EPV | 203.91 - 236.77 | 220.34 | -88.8% |
| DDM - Stable | 311.19 - 635.17 | 473.18 | -75.9% |
| DDM - Multi | 577.22 - 885.62 | 696.64 | -64.5% |
| Market Cap (mil) | 314,874.22 |
| Beta | 0.54 |
| Outstanding shares (mil) | 160.56 |
| Enterprise Value (mil) | 314,240.12 |
| Market risk premium | 8.31% |
| Cost of Equity | 12.61% |
| Cost of Debt | 13.07% |
| WACC | 12.60% |